| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study
|
Batra, Ullas
|
|
|
26 |
7 |
p. 1221-1228
|
artikel
|
| 2 |
Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib
|
Watanabe, Daichi
|
|
|
26 |
7 |
p. 1257-1263
|
artikel
|
| 3 |
Benefit of intensive chemotherapy for elderly patients aged 80 years or older with metastatic colorectal cancer: a state-wide multicenter cohort study
|
Nakayama, Yujiro
|
|
|
26 |
7 |
p. 1248-1256
|
artikel
|
| 4 |
Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma
|
Motai, Risa
|
|
|
26 |
7 |
p. 1188-1195
|
artikel
|
| 5 |
Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
|
Aogi, Kenjiro
|
|
|
26 |
7 |
p. 1229-1236
|
artikel
|
| 6 |
Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer
|
Sato, Kentaro
|
|
|
26 |
7 |
p. 1272-1284
|
artikel
|
| 7 |
Computed tomography findings for predicting the future occurrence of pancreatic cancer: value of pancreatic volumetry
|
Kawaji, Yuki
|
|
|
26 |
7 |
p. 1304-1313
|
artikel
|
| 8 |
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
|
Aogi, Kenjiro
|
|
|
26 |
7 |
p. 1237
|
artikel
|
| 9 |
Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study
|
Shimada, Muneaki
|
|
|
26 |
7 |
p. 1314-1321
|
artikel
|
| 10 |
Efficacy and safety of 188Re-HEDP in lung cancer patients with bone metastases: a randomized, multicenter, multiple-dose phase IIa study
|
Chen, Ping
|
|
|
26 |
7 |
p. 1212-1220
|
artikel
|
| 11 |
Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database
|
Qi, Wei-xiang
|
|
|
26 |
7 |
p. 1203-1211
|
artikel
|
| 12 |
Jab1/Cops5: a promising target for cancer diagnosis and therapy
|
Yuan, Chunjue
|
|
|
26 |
7 |
p. 1159-1169
|
artikel
|
| 13 |
Laboratory prognostic score for predicting 14-day mortality in terminally ill patients with gynecologic malignancy
|
Onishi, Kazuma
|
|
|
26 |
7 |
p. 1345-1352
|
artikel
|
| 14 |
Otorhinolaryngologists/head and neck surgeons’ knowledge, attitudes, and practices regarding fertility preservation in young cancer patients treated with chemotherapy: an anonymous questionnaire survey
|
Akisada, Naoki
|
|
|
26 |
7 |
p. 1196-1202
|
artikel
|
| 15 |
Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy
|
Kano, Satoshi
|
|
|
26 |
7 |
p. 1179-1187
|
artikel
|
| 16 |
Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases
|
Yasunaga, Masafumi
|
|
|
26 |
7 |
p. 1330-1335
|
artikel
|
| 17 |
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study
|
Kato, Takeshi
|
|
|
26 |
7 |
p. 1238-1247
|
artikel
|
| 18 |
Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma
|
Suzuki, Kazuhiro
|
|
|
26 |
7 |
p. 1322-1329
|
artikel
|
| 19 |
Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: a 20-year review at a single institution
|
Inaka, Yuko
|
|
|
26 |
7 |
p. 1170-1178
|
artikel
|
| 20 |
The carcinoembryonic antigen ratio is a potential predictor of survival in recurrent colorectal cancer
|
Suzuki, Yumi
|
|
|
26 |
7 |
p. 1264-1271
|
artikel
|
| 21 |
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy
|
Takeda, Tsuyoshi
|
|
|
26 |
7 |
p. 1293-1303
|
artikel
|
| 22 |
Tumor budding as a predictive marker for 5-fluorouracil response in adjuvant-treated stage III colorectal cancer
|
Akabane, Shintaro
|
|
|
26 |
7 |
p. 1285-1292
|
artikel
|
| 23 |
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
|
Miyagi, Etsuko
|
|
|
26 |
7 |
p. 1336-1344
|
artikel
|
Tijdschrift beschrijving